Pharmaceutical compositions for improving bone loss of hyperthyroid high-conversion type and reduction of biomechanical properties of bone

A composition and high-conversion technology, applied in drug combination, food science, drug delivery, etc., can solve the problem of undiscovered fructose-specific transporter

Inactive Publication Date: 2018-09-28
GUANGDONG SPRINGYOUNG BIOTECH +1
View PDF7 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the expression of fructose-specific transporters has not been found in bone tissue, and there are few studies on the effects of fructose and glucose in monosaccharides on bone
Studies have found that compared with animals on a normal diet, a high-fructose diet has no adverse effects on bone tissue in animals, and even compared with a high-glucose diet, a high-fructo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical compositions for improving bone loss of hyperthyroid high-conversion type and reduction of biomechanical properties of bone
  • Pharmaceutical compositions for improving bone loss of hyperthyroid high-conversion type and reduction of biomechanical properties of bone
  • Pharmaceutical compositions for improving bone loss of hyperthyroid high-conversion type and reduction of biomechanical properties of bone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] In order to verify the effect of the Danshen fructose composition of the present invention on the loss of bone height conversion caused by hyperthyroidism and the improvement of bone mechanical properties, the inventors conducted the following animal experiments.

[0023] Animal experiments used 96 SPF grade male SD rats, 3 months old, weighing 325±25g, provided by Guangxi Medical University, certificate number: SCXK Gui 2014-0002. Breeding environment: clean, room temperature 23°C, relative humidity 70%, free access to water and food, reared in separate cages. Rats were fed with standard feed (1.11% calcium content, 0.74% phosphorus content, and 1510 IU / kg vitamin D), which were purchased from Beijing Keao Xieli Co., Ltd. After one week of adaptive feeding, the experiment was carried out, and the period was 12 weeks. During the experiment, the rats were observed and recorded for eating, drinking and activities every day, weighed every week, and adjusted the dosage acc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides pharmaceutical compositions for improving the bone loss of hyperthyroid high-conversion type and the reduction of the biomechanical properties of the bone, and relates to an extract of a Chinese medicinal Danshen, or the formula and the production process of pharmaceutical compositions for improving the bone loss of high-conversion type and the reduction of the biomechanicalproperties of the bone caused by the hypersplenism of the thyroid, which is prepared from the following components in parts by weight: 0.1 to 0.3 g of a danshensu and 5 g of crystalline fructose, thepharmaceutical compositions are characterized by being prepared into an injection. The invention further discloses a formula and production process of the injection, a granule and a non-alcoholic beverage. The high-dose thyroxine-induced hyperthyroid high-conversion bone loss animal model proves that the pharmaceutical composition prepared from the danshensu and the fructose can influence the bone metabolism of the rat, promote the bone formation, inhibit the bone resorption, increase the bone mass, improve the bone mineral density and the bone mineral salt content, and improve the performance of the bone biomechanics, and has a good preventive effect on the damage of the bone biological biomechanical properties of the hyperthyroid osteoporosis.

Description

technical field [0001] The invention belongs to the technical field of health food and medicine production, and specifically relates to a formula and a production process of a group of pharmaceutical compositions for improving high-transition bone loss and bone biomechanical performance decline caused by hyperthyroidism. Background technique [0002] Hyperthyroidism refers to the general term for clinical diseases characterized by systemic hypermetabolic hyperactivity caused by elevated thyroid hormone levels in the human body, causing increased excitability of the body's nervous, circulatory, and digestive systems. It is a common organ-specific autoimmune disease in clinical practice. Thyroid disease is also a high-energy-consuming disease that consumes too much energy in the human body. Clinically, the disease often manifests as hypermetabolic syndromes such as palpitations, insomnia, irritability, and weight loss. Thyroid disease represented by hyperthyroidism has become...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/537A61K31/7004A61K9/16A61K9/08A61P5/16A61P19/10A23L2/38A23L2/52A23L33/105A61K31/11A61K31/192A61K35/618
CPCA61P5/16A61P19/10A23L2/38A23L2/52A23L33/105A61K9/0019A61K9/08A61K9/16A61K31/11A61K31/192A61K31/7004A61K35/618A61K36/286A61K36/484A61K36/537A23V2002/00A61K2236/331A61K2236/333A61K2236/39A61K2236/53A23V2200/30A23V2200/306A61K2300/00
Inventor 吴铁徐伟雄崔燎
Owner GUANGDONG SPRINGYOUNG BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products